Eco R1 Capital, LLC Zai Lab LTD Transaction History

Eco R1 Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $2.84 Million - $4.93 Million	127,434 Added 6.28%	2,157,686 $66.2 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $13.7 Million - $20.8 Million	-401,633 Reduced 16.52%	2,030,252 $69.4 Million
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $4.83 Million - $10.4 Million	208,673 Added 9.39%	2,431,885 $84.3 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $61.7 Million - $143 Million	2,223,212 New	2,223,212 $97.8 Million
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $2.02 Million - $2.81 Million	-78,519 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$21.71 - $31.54 $10.7 Million - $15.5 Million	-490,858 Reduced 86.21%	78,519 $2.32 Million
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $3.28 Million - $5.42 Million	219,377 Added 62.68%	569,377 $13.2 Million
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $6.23 Million - $8.87 Million	350,000 New	350,000 $6.82 Million
Q4 2017 Feb 14, 2018	SELL	$21.23 - $34.09 $3.39 Million - $5.44 Million	-159,535 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $4.31 Million - $4.96 Million	159,535	159,535 $4.31 Million

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.